EUCTR2005-003582-16-IT进行中（未招募）不适用
Dose-dense treatment with gemcitabine, epirubicin and paclitaxel GET combination in advanced breast cancer a phase II parallel study
AZIENDA OSPEDALIERA POLICLINICO DI MODENA0 个研究点开始时间: 2007年4月4日最近更新:
适应症
相关药物
试验速览
- 阶段
- 不适用
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- Female
入选标准
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range
排除标准
- 未提供
研究者
相似试验
已完成
2 期
Chemoradiation with gemcitabine in combination with panitumumab for patients with locally advanced pancreatic cancer.pancreas cancer10017991Pancreatic cancerNL-OMON36705Vrije Universiteit Medisch Centrum63
进行中（未招募）
1 期
Chemoradiation with gemcitabine in combination with panitumumab for patients with locally advanced pancreatic cancer.Inoperable locally advanced pancreatic cancer.MedDRA version: 12.1Level: LLTClassification code 10033606Term: Pancreatic cancer non-resectableEUCTR2010-018327-26-NLVU University Medical Center
已完成
不适用
eoadjuvant combined chemotherapy with gemcitabine, cisplatin and zoledronic acid against muscle invasive bladder cancerbladder cancerJPRN-UMIN000003146Department of Urology, Graduate School of Biomedical Sciences Hiroshima University30
进行中（未招募）
不适用
Chemoradiation with once weekly gemcitabine for invasive bladder cancerInvasive transitional cell bladder cancerEUCTR2004-003906-81-LTOncology Institute of Vilnius University
招募中
2 期
Chemotherapy using gemcitabine and docetaxel for advanced bone and soft tissue sarcomaadvanced bone and soft tissue tumorJPRN-UMIN000021202agoya City University, Graduate School of Medical Science10